EURORDIS welcomes European Parliament’s defence of investment in EU health projects
23 October 2024, Brussels – EURORDIS-Rare Diseases Europe welcomes today’s European Parliament vote, which decisively uphold the commitment to maintaining the 2025 budget against the Council of the EU’s proposed cuts.
By opposing reductions to critical programmes like Horizon Europe and EU4Health, the Parliament has reaffirmed its commitment to preserving essential investments in health and research that benefit millions across Europe.
Responding to the vote, Valentina Bottarelli, Public Affairs Director at EURORDIS, said:
Text Name
Download PDF
About EURORDIS-Rare Diseases Europe
EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of over 1,000 rare disease organisations from 74 countries that work together to improve the lives of the 30 million people living with a rare disease in Europe. By connecting people, families, and rare disease groups, as well as by bringing together all stakeholders and mobilising the rare disease community, EURORDIS strengthens the patient voice and shapes research, policies, and services.
Contact
Julien Poulain
Communications Manager
EURORDIS-Rare Diseases Europe
Julien.poulain@eurordis.org
+33 6 42 98 14 32